MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Anacor Pharmaceuticals Company Profile (NASDAQ:ANAC)

Consensus Ratings for Anacor Pharmaceuticals (NASDAQ:ANAC) (?)
Ratings Breakdown: 2 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $134.30 (35.38% upside)

Analysts' Ratings History for Anacor Pharmaceuticals (NASDAQ:ANAC)
Show:
DateFirmActionRatingPrice TargetActions
5/18/2016MizuhoDowngradeBuy -> Neutral$98.00 -> $99.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016WedbushDowngradeOutperform -> Neutral$148.00 -> $99.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2015JMP SecuritiesInitiated CoverageOutperform$173.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2015Bank of AmericaUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2015Goldman SachsUpgradeNeutral -> Buy$195.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2014Avondale PartnersInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Anacor Pharmaceuticals (NASDAQ:ANAC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/10/2016Q116($0.35)($0.36)$19.53 million$17.54 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2016Q415($0.30)($0.43)$27.93 million$21.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315($0.23)($0.37)$25.60 million$24.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.32)($0.30)$18.55 million$21.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115($0.49)($0.30)$9.20 million$15.26 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q414($0.61)($0.24)$4.74 million$9.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314($0.66)($0.74)$3.67 million$3.96 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.63)($0.58)$3.03 million$2.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.39)($0.51)$2.82 million$4.15 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2014Q413($0.39)$3.01$2.85 million$8.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.39)($0.41)$2.57 million$3.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q2 2013($0.39)($0.36)$2.60 million$3.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013($0.39)($0.42)$2.57 million$1.71 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2013Q4 2012($0.45)($0.36)$3.25 million$3.28 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.45)($0.46)$3.18 million$2.47 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2012($0.45)($0.47)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/10/2012($0.44)($0.48)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2012($0.35)($0.52)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2011($0.41)($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2011($0.45)($0.54)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011($0.31)($0.49)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Anacor Pharmaceuticals (NASDAQ:ANAC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.45)($0.30)($0.38)
Q2 20162($0.41)($0.36)($0.39)
Q3 20162($0.44)($0.33)($0.39)
Q4 20162($0.74)($0.53)($0.64)
Q1 20171($0.53)($0.53)($0.53)
Q2 20171$0.52$0.52$0.52
Q3 20171$1.32$1.32$1.32
Q4 20171$1.67$1.67$1.67
(Data provided by Zacks Investment Research)
Dividend History for Anacor Pharmaceuticals (NASDAQ:ANAC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Anacor Pharmaceuticals (NASDAQ:ANAC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/1/2016Graeme BellCFOSell751$99.28$74,559.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016Keith R LeonardDirectorSell9,000$99.70$897,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Anders D HoveDirectorSell353,881$99.59$35,243,008.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016Ryan T SullivanEVPSell3,125$66.33$207,281.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2016Anders D HoveDirectorSell229,301$71.10$16,303,301.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Paul L BernsCEOSell37,500$60.31$2,261,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/19/2016Vincent P. IppolitoEVPSell20,000$95.41$1,908,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2016Lee ZaneSVPSell1,466$89.57$131,309.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Paul L. BernsCEOSell2,533$112.35$284,582.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Ryan T. SullivanVPSell733$111.78$81,934.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Vincent P. IppolitoEVPSell855$112.28$95,999.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Paul L. BernsCEOSell20,000$117.26$2,345,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Ryan T. SullivanVPSell10,000$110.41$1,104,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Lee ZaneSVPSell14,000$139.84$1,957,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Paul L. BernsCEOSell20,000$139.83$2,796,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Paul L BernsCEOSell20,000$138.69$2,773,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Lee ZaneSVPSell12,000$69.05$828,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2015Jacob J PlattnerVPSell8,920$63.73$568,471.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2015Carmen R RodriguezVPSell61,942$62.73$3,885,621.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Ryan T SullivanVPSell3,125$53.61$167,531.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Paul L BernsCEOSell50,000$63.64$3,182,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2015Jacob J PlattnerVPSell8,920$62.81$560,265.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Geoffrey M ParkerCFOBuy3,000$52.43$157,290.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Jacob J PlattnerVPSell8,920$55.60$495,952.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Lee ZaneSVPSell12,000$56.44$677,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2015Sanjay ChandaSVPSell5,000$45.00$225,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Vincent P IppolitoEVPSell9,000$43.88$394,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Jacob J PlattnerVPSell6,875$44.02$302,637.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Kirk R MaplesSVPSell600$43.95$26,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Jacob J PlattnerVPSell6,875$32.09$220,618.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2014Paul L BernsCEOSell25,000$30.82$770,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Lucy ShapiroDirectorSell289,685$35.11$10,170,840.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2014Lee ZaneSVPSell4,900$36.09$176,841.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Kirk R MaplesSVPSell60,000$36.52$2,191,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Jacob J PlattnerVPSell6,875$33.34$229,212.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Kirk R MaplesSVPSell600$33.38$20,028.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014Sanjay ChandaSVPSell5,000$35.00$175,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Jacob J PlattnerVPSell6,875$29.32$201,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Jacob J PlattnerVPSell6,875$24.47$168,231.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/26/2014Anders D HoveDirectorSell20,000$25.00$500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014Anders D HoveDirectorSell740,000$24.87$18,403,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2014Anders D HoveDirectorSell90,000$24.99$2,249,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Sanjay ChandaSVPSell10,000$24.25$242,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Geoffrey M ParkerCFOBuy6,590$21.82$143,793.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Mark LeschlyDirectorSell13,067$22.50$294,007.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2014Kirk MaplesSVPSell1,500$14.15$21,225.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2014Kirk MaplesSVPSell1,500$15.60$23,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2014Geoffrey ParkerCFOBuy5,000$20.11$100,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2014Lucy ShapiroDirectorSell80,000$21.14$1,691,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2014Kirk MaplesSVPSell3,000$22.39$67,170.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Geoffrey ParkerCFOBuy2,410$22.60$54,466.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2014David PerryCEOSell65,000$20.22$1,314,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Kirk MaplesSVPSell3,000$19.33$57,990.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2014David PerryCEOSell15,000$17.00$255,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2014Kirk MaplesSVPSell3,000$20.27$60,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014David PerryCEOSell65,000$16.32$1,060,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013David PerryCEOSell40,328$16.23$654,523.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2013Geoffrey ParkerCFOBuy10,000$13.40$134,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2013Geoffrey ParkerCFOBuy10,000$12.85$128,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Kirk MaplesSVPSell1,052$9.71$10,214.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013Geoffrey ParkerCFOBuy50,000$8.34$417,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013Geoffrey M ParkerCFOBuy23,046$5.20$119,839.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2013Geoffrey M ParkerCFOBuy20,000$5.22$104,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2013Kirk R MaplesSVPSell5,600$5.39$30,184.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012Kirk R MaplesSVPSell3,000$5.22$15,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2012Kirk R MaplesSVPSell3,000$5.81$17,430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2012Lucy ShapiroDirectorSell30,000$6.67$200,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2012Geoffrey M ParkerCFOBuy5,000$6.19$30,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Anacor Pharmaceuticals (NASDAQ:ANAC)
DateHeadline
06/30/16 02:35 PMBill Gates Calls U.S. Drug Pricing System ‘Better Than Most’
06/30/16 10:22 AMAnacor Pharmaceuticals, Inc. (NASDAQ:ANAC) Company Rating and Target Watch - Telanagana Press
06/29/16 02:30 PMWere Analysts Bearish Anacor Pharmaceuticals Inc (NASDAQ:ANAC) This Week? - Engelwood Daily
06/28/16 07:43 AMTop Stock Pick for Quarter: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Engelwood Daily
06/27/16 02:49 PMAnacor Pharmaceuticals, Inc. (NASDAQ:ANAC) Earnings Glance and Target Price Review - Engelwood Daily
06/27/16 02:49 PMPfizer Inc. (NYSE:PFE) completed its acquisition of Anacor Pharmaceuticals, Inc - Inside Trade
06/27/16 07:15 AMAnacor Pharmaceuticals, Inc. (ANAC) Broker Price Targets For The Coming Week - Fiscal Standard
06/24/16 07:42 PMStock Tracing Lower on the Week Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Engelwood Daily
06/24/16 02:30 PMAnacor Pharmaceuticals Inc.: Pfizer Completes Acquisition Of Anacor - The Wall Street Transcript
06/24/16 08:56 AMNew Broker Ratings For Anacor Pharmaceuticals, Inc. (ANAC) - FTSE News
06/24/16 08:56 AMHC Stocks News Ring: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Opko Health Inc. (NYSE:OPK) - share market updates (press release)
06/24/16 08:22 AMANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Triggering Event -
06/23/16 07:37 PMWhy Pfizer (PFE) is a Great Stock to Buy for the Long Run -
06/22/16 02:30 PMAnacor Pharmaceuticals (NASDAQ:ANAC) Analyst Rating Consensus - Trade Calls
06/21/16 07:16 AMHC Stocks Updates: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Mylan NV (NASDAQ:MYL) - share market updates (press release)
06/20/16 02:29 PMReview of Analysts Ranking: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) , Anacor Pharmaceuticals, Inc. (NASDAQ ... - Street Updates
06/20/16 08:59 AMDermatological Drugs Market To See 4.29% CAGR Driven By Pharmaceutical Industry To 2018 : Radiant Insights,Inc
06/19/16 07:14 AMAnacor Pharmaceuticals, Inc. (ANAC) Analyst Price Targets For The Coming Week - Fiscal Standard
06/19/16 07:14 AMAnacor Pharmaceuticals, Inc. Pipeline Review, Industry Analysis, Market Size and Forecast 2016 – 2020 - Medgadget.com (blog)
06/17/16 10:25 AMGlobal Tuberculosis Pipeline 2016 Market Report on 64 Companies
06/17/16 10:25 AMNoteworthy Thursday Option Activity: ANAC, CACC, BMRN
06/15/16 02:33 PMPerformance to see: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - News Oracle
06/14/16 02:28 PMPrice Target Highlight: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - News Oracle
06/14/16 02:28 PMEarnings Expectations of the Stocks: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC), Juniper Networks, Inc. (NYSE ... - Beacon Chronicle
06/14/16 02:28 PMNotable Analysts Recommendation to Monitor: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) , Relypsa, Inc ... - Street Updates
06/13/16 02:29 PMHot Stock seeking Investors: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - News Oracle
06/13/16 02:29 PMBest Stocks for Investors: Nucor Corporation (NYSE:NUE), Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Beacon Chronicle
06/13/16 02:29 PMHC Stocks Reports: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Community Health Systems (NYSE:CYH) - share market updates (press release)
06/10/16 10:54 AMBuy Sell or Hold? - Carnival Corporation (NYSE:CCL), Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Beacon Chronicle
06/10/16 10:54 AMAnalyst's Checklist Stocks: Pfizer, Inc. (NYSE:PFE) , Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Street Updates
06/09/16 11:24 AMAnalyst Recommended Stock: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - News Oracle
06/09/16 11:24 AMPrice Target Summary: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC), 3D Systems Corporation (NYSE:DDD) - Beacon Chronicle
06/08/16 03:30 PMANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Sub -
06/08/16 02:57 PMRatings Analysis of: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - News Oracle
06/08/16 02:57 PMANACOR PHARMACEUTICALS INC. (NASDAQ:ANAC) Financial Condition Compared to S&P 500 - CML News
06/08/16 10:57 AMGlobal anacor pharmaceuticals, Inc market growth trends, key players, competitive strategies and forecasts 2016 ... - WhaTech
06/07/16 02:31 PMStock under consideration: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - News Oracle
06/07/16 02:31 PMAnalyst Recommended Stocks: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC), Memorial Resource Development ... - Beacon Chronicle
06/07/16 02:31 PMStocks Recommendation Update: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) , Anacor Pharmaceuticals, Inc ... - Street Updates
06/07/16 10:30 AMGlobal Anacor Pharmaceuticals, Inc Market Growth Trends, Key Players, Competitive Strategies and Forecasts 2016 ... - RD News Mag
06/06/16 07:43 PMWill Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) Surprise Analysts? - Investor Newswire
06/05/16 10:23 AMWhy Anacor Pharmaceuticals, Inc. Stock Jumped 58.3% in May - Motley Fool
06/05/16 09:28 AMWhy Anacor Pharmaceuticals, Inc. Stock Jumped 58.3% in May - Here's what made the purveyor of novel ointments' share price skyrocket last month.
06/03/16 02:30 PMPrice Target by Brokers: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC), Commercial Metals Company (NYSE:CMC) - Beacon Chronicle
06/03/16 10:56 AMInvestor Alert: Buyout of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) under Investigation - GroundReport
06/03/16 10:56 AMInvestor's observing Biotech Stocks: Baxalta Incorporated (NYSE:BXLT) , Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Is stories
06/02/16 02:34 PMMid-day Stocks to Lookout: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), CVS Health Corp (NYSE:CVS), Gilead ... - The Point Review - The Point ReviewMid-day Stocks to Lookout: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), CVS Health Corp (NYSE:CVS), Gilead ...The Point ReviewShares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) fell -0.09% to $99.31 at 11:44 AM EDT. The stock attained the volume of 1.17 Million shares recently versus average trading volume of 2.68 Million shares. If we take a look on its volatility, 0.68 ...
06/02/16 11:09 AMHealthcare stocks to Observe: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) , Anacor Pharmaceuticals, Inc. (NASDAQ ... - Is stories - Is storiesHealthcare stocks to Observe: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) , Anacor Pharmaceuticals, Inc. (NASDAQ ...Is storiesCelator Pharmaceuticals Inc. (NASDAQ:CPXX) increased +0.40% to $30.20 while traded 5.45 million shares on 6/1/2016. The stock price negotiated for value between $29.97 to $30.23 in recent trading session. During the past 52 weeks, the stock's price ...Stocks Under Review: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Gilead Sciences, Inc. (NASDAQ:GILD), Celldex ...The Point ReviewMomentum Stock in Focus: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC)CWRU ObserverBuy, Sell Or Hold Rating For Anacor Pharmaceuticals, Inc. (ANAC)?Share Trading NewsStreet Updates -The Post -HNNall 13 news articles »
06/01/16 08:36 PMStocks Under Review: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Gilead Sciences, Inc. (NASDAQ:GILD), Celldex ... - The Point Review - Is storiesStocks Under Review: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Gilead Sciences, Inc. (NASDAQ:GILD), Celldex ...The Point ReviewShares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) flew 0.10% to $99.40 at 11:48 AM EDT. The stock attained the volume of 1.03 Million shares recently versus average trading volume of 2.70 Million shares. If we take a look on its volatility, 0.68 ...Momentum Stock in Focus: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC)CWRU ObserverBuy, Sell Or Hold Rating For Anacor Pharmaceuticals, Inc. (ANAC)?Share Trading NewsWere Analysts Bullish Anacor Pharmaceuticals Inc (NASDAQ:ANAC) This Week?HNNStreet Updates -Is storiesall 12 news articles »
06/01/16 10:51 AMStock Review and Earnings Check on Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - HNN - Stock Review and Earnings Check on Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Anacor Pharmaceuticals, Inc.and more »
About Anacor Pharmaceuticals

Anacor Pharmaceuticals logoAnacor Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. The Company's lead product candidate, AN2728 is an investigational non-steroidal topical PDE-4 inhibitor in development for the potential treatment of mild-to-moderate atopic dermatitis and psoriasis. The Company's product KERYDIN (tavaborole) topical solution is an oxaborole antifungal. The Company also has a pipeline of other internally discovered topical and systemic boron-based compounds in early stages of research and development, which include AN3365. The Company's compound, AN5568 (SCYX-7158), is licensed to Drugs for Neglected Diseases initiative (DNDi) for the potential treatment of human African trypanosomiasis (sleeping sickness).

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ANAC
  • CUSIP: 03242010
Key Metrics:
  • Previous Close: $99.20
  • 50 Day Moving Average: $93.23
  • 200 Day Moving Average: $81.52
  • P/E Ratio: N/A
  • P/E Growth: 3.74
  • Market Cap: $4.50B
  • Current Quarter EPS Consensus Estimate: $-1.69 EPS
Additional Links:
Anacor Pharmaceuticals (NASDAQ:ANAC) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha